ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE
Autor: | Maria Glezer, Astashkin, E. I., Sokolova, I. N. |
---|---|
Jazyk: | ruština |
Rok vydání: | 2013 |
Předmět: |
Chronotropic
medicine.medical_specialty Combination therapy if channel blocker heart failure β-adrenoblockers combination therapy Angina angina Quality of life Internal medicine medicine Diseases of the circulatory (Cardiovascular) system coronary heart disease business.industry ivabradine medicine.disease Coronary heart disease Heart failure RC666-701 Ambulatory Cardiology prognosis Cardiology and Cardiovascular Medicine business Ivabradine medicine.drug |
Zdroj: | Кардиоваскулярная терапия и профилактика, Vol 12, Iss 5, Pp 81-86 (2013) Scopus-Elsevier |
ISSN: | 2619-0125 1728-8800 |
Popis: | The study aim was to assess the importance of adequate administration of medications with negative chronotropic effect in the improvement of clinical course and prognosis among patients with coronary heart disease (CHD) and heart failure. The possibility and appropriateness of combination therapy with β-adrenoblockers (β-AB) and an If channel blocker ivabradine is justified. The authors analyse current real-world trends in the administration and dose titration of these medications among ambulatory Russian patients. Russian doctors need to be more active in the treatment of patients with CHD and heart failure and better understand the need for and benefits of dose titration of medications with negative chronotropic effect, as well as the importance of combination therapy for the improvement of clinical course, prognosis, and quality of life. |
Databáze: | OpenAIRE |
Externí odkaz: |